12/02/2025 13:00
AdvanCell Initiates Phase 2 Expansion Trial of ADVC001, a Novel Targeted Alpha Therapy for Prostate Cancer

AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced the initiation of the TheraPb Phase 2 expansion trial (NCT05720130) evaluating its lead investigational candidate, ADVC001, in metastatic prostate cancer. The news follows the encouraging Phase 1b dose escalation results presented at the European Society for Medical Oncology (ESMO) 2025 congress that showed a favorable safety profile and compelling anti-tumor activi...

AFP photojournalist Ina Fassbender awarded first prize in the 2024 VDS Sports Photo Competition

Ina Fassbender secured first place for her photograph ‘Looking Forward to Euro’, taken in Essen during the 2024 UEFA European football championship.

Ina Fassbender secured first place for her photograph ‘Looking Forward to Euro’, taken in Essen during the 2024 UEFA European football championship.

Phil Chetwynd on France 24: AI and the Future of Journalism

AFP’s Global News Director, Phil Chetwynd, appeared on France 24’s Scoop on Friday, 7 February, to discuss artificial intelligence and its impact on journalism.

AFP’s Global News Director, Phil Chetwynd, appeared on France 24’s Scoop on Friday, 7 February, to discuss artificial intelligence and its impact on journalism.